Please use this identifier to cite or link to this item:
https://ptsldigital.ukm.my/jspui/handle/123456789/473264Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.date.accessioned | 2023-10-03T10:37:12Z | - |
| dc.date.available | 2023-10-03T10:37:12Z | - |
| dc.date.issued | 2020-10-11 | |
| dc.identifier.other | ukmvital:124218 | |
| dc.identifier.uri | https://ptsldigital.ukm.my/jspui/handle/123456789/473264 | - |
| dc.language.iso | en | |
| dc.relation.haspart | The Star | |
| dc.subject | Ovarian cancer | |
| dc.subject | BRCA1 | |
| dc.subject | BRCA2 | |
| dc.subject | Olaparib | |
| dc.subject | Drug | |
| dc.title | Improving access to ovarian cancer drug | |
| dc.type | News Article | |
| Appears in Collections: | Medical & Health Sciences Newspaper Article / Artikel Surat Khabar Perubatan & Sains Kesihatan | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| ukmvital_124218+Source01+Source010.PDF Restricted Access | 1.79 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.